IMR
data caveat$674M—
Imricor Medical Systems
Cardiac
Vision-MR ablation system for cardiac catheter ablation under real-time MRI guidance
Data HealthTrials2 of 2 active · stale enrollment
No cash data on fileFigures from ASX filings · not financial advice
[ VITALS ]
Cash on Hand
—
Runway
—Market Cap
$674M
Burn Rate
—
Shares Outstanding
321M
Pipeline Assets
2
3M Price
IMR.ASX$2.100+4.0% 3M
Low $1.815High $2.200
Pipeline Assets (2)
Vision-MR Ablation CatheterCardiac arrhythmia (MRI-guided ablation)
ApprovedVision-MR Deflectable SheathMRI-guided cardiac catheter navigation
ApprovedDiscovery
Preclinical
Ph 1
Ph 1/2
Ph 2
Ph 2/3
Ph 3
NDA
Approved
Vision-MR Ablation Catheter
Capital Raises & Buybacks
show_chart
No capital raise or buyback data
Director Options & Rights
Director
Outstanding
Ex. Price
Expiry
No option data entered yet
Catalysts (2)
SpeculativeremoveMed1 Dec 2026
SpeculativeremoveMed31 Dec 2026
| Event | Type | Confidence | Impact | Date | Status |
|---|---|---|---|---|---|
Delivery Consistency Index
Historical delivery and spending consistency — data is limited for recently added companies.
Track record will build as data accumulates — we need completed catalysts with original guidance dates, or at least two quarterly 4Cs, before scoring kicks in.
Clinical Trials(2)
2 activeClinicalTrials.gov ↗
NARecruitingEnrollment stale · 671d
RF Ablation
Atrial Flutter Ablation in the iCMR
Atrial Flutter Typical
18 Years+
Primary endpoint Primary Efficacy Endpoint: Bi-directional block confirmation
NARecruitingEnrollment stale · 377d
Vision-MR Ablation Catheter 2.0
VT Ablation in the iCMR
Ventricular Tachycardia
18 Years+
Primary endpoint Primary Efficacy Endpoint